newsfilter
← Latest News
ClinicalTrials.gov·

Study 102: Multiple Ascending Dose Study of ALLN-346 (Engineered Urate Oxidase) - NCT04829435

Incidence of Treatment Emergent Adverse Events (TEAEs), Serum ALLN-346